SCHEMBL4773987

SCHEMBL4773987

CCc1c(CC(N)=O)oc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EYA3 Q99504 3/20 0.47
SLC22A12 Q96S37 2/20 0.47
CYP2C19 P33261 7/20 0.44
CYP2C9 P11712 6/20 0.44
MEN1 O00255 2/20 0.44
ABCB11 O95342 2/20 0.44
LMNA P02545 2/20 0.44
TTR P02766 2/20 0.44
PGR P06401 2/20 0.44
ADRA2A P08913 2/20 0.44
TBXA2R P21731 2/20 0.44
OPRM1 P35372 2/20 0.44
SLC6A3 Q01959 2/20 0.44
KMT2A Q03164 2/20 0.44
BIRC5 O15392 1/20 0.44
HTR1A P08908 1/20 0.44
DRD1 P21728 1/20 0.44
PTGS1 P23219 1/20 0.44
SLC6A2 P23975 1/20 0.44
PDE4A P27815 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11365473 0.81 KCNH2 (0.47) EYA3SLC22A12CYP2C19CYP2C9MEN1
SCHEMBL28131940 0.81 TEAD1 (0.51) MEN1LMNAKMT2AMAPTALDH1A1
SCHEMBL5860509 0.79 EYA3 (0.49) EYA3SLC22A12CYP2C19CYP2C9MEN1
SCHEMBL13348986 0.78 ABCB1 (0.46) EYA3SLC22A12CYP2C19CYP2C9MEN1
Formamide SCHEMBL23320479 0.78 EYA3 (0.46) EYA3SLC22A12CYP2C19CYP2C9MEN1
Oxalic Acid SCHEMBL28849573 0.77 ALDH1A1 (0.49) MEN1LMNAKMT2AMAPTALDH1A1
SCHEMBL8788305 0.76 EYA3 (0.51) EYA3SLC22A12CYP2C19CYP2C9MEN1
Sulfuric Acid SCHEMBL28171448 0.76 KMT2A (0.47) LMNAKMT2AMAPTALDH1A1POLB
SCHEMBL1252238 0.76 PTPN1 (0.47) EYA3SLC22A12CYP2C19CYP2C9MEN1
SCHEMBL4095186 0.75 PLK1 (0.46) EYA3SLC22A12CYP2C19CYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 EP disclosed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 WO disclosed